Company Announcements In a management buyout, Harvard Bioscience sold its Union Biometrica division, the remaining portion of its Capital Equipment business, in October 2008 for $1 in cash, the assumption of certain liabilities and an earn-out. Harvard Bioscience named Thomas McNaughton, most recently CFO of Tivoli Audio, CFO in November 2008. Jock Fyfe Lennox, senior […]

GE Purchases Whatman The acquisition (see IBO 2/15/08) was evidence that GE Life Science is still intent on growing its business. The $713 million purchase was also a testament to the importance of sample preparation products to life science suppliers. Agilent Expands Materials Science Business Four acquisitions this year (see IBO 3/15/08, 6/30/08, 7/15/08) added […]

Cambridge, MA 12/2/08; Washington, DC 12/2/08; Washington, DC 12/3/08—Helicos BioSciences, which this year commercialized the HeliScope DNA sequencer, has announced the appointment of Ronald Lowy as part-time CEO. He replaces Steve Lombardi, who will continue as president and as a Board member. Mr. Lowy was president and CEO of Fisher Scientific from November 2004 to […]

Santa Clara, CA 12/3/08—Symyx Technologies, a provider of informatics and automation products, instruments and services, has announced a restructuring that is designed to reduce 2009 expenses by an estimated $15 million, excluding restructuring charges. The company will combine its Tools and Research operations to form the High Productivity Research unit, which will be organized by […]

Carlsbad, CA 11/4/08; Carlsbad, CA and Norwalk, CT 11/11/08—Invitrogen and Applied Biosystems’ merger has received clearance from the European Commission (see IBO 6/15/08). As a result, the companies are expected to complete the transaction on November 21. Invitrogen has also announced that the company will be renamed Life Technologies. Instruments and systems will continue to […]

Waltham, MA 11/10/08—PerkinElmer has announced that it will refocus its business into two areas, Human Health and Environmental Health, beginning January 1, 2009. The Human Health business will include the company’s Genetic Screening, Bio-discovery and Medical Imaging operating units and will be led on an interim basis by company President and CEO Robert Friel. The […]

Company Announcements YSI named Dr. Edward King vice president of R&D and chief technology officer in June. In July, PerkinElmer named Alan Fletcher, PhD, vice president of business development for the Life and Analytical Sciences business with the responsibility for growing the Bio-discovery business. He joined the company from GE Healthcare. GE appointed John Dineen, […]

New Milton, UK 7/31/08—Genetix has named Charles de Rohan CEO effective September 15. Mr. de Rohan is currently divisional vice president, Scientific Leadership and Global Accounts EMEA, for Abbott Laboratories’s Diagnostic Division. He will replace Mark Reid, who will serve as a nonexecutive director and strategic consultant for Genetix. “Charles’ extensive experience in the clinical […]